Plus, the largest US gas producer at a peer discount...
Plus, a surprising med-tech name riding the GLP-1 boom...
One stock pick from a top-ranked analyst with an implied upside of 100% or more.
September is historically the market's worst month. Here's where the money may be hiding.
Plus, a cancer-imaging play with a looming FDA date... and a whopping 95% implied upside.
Plus, the year’s biggest chip IPO still has plenty of room to run...
Plus, a Street-high target on a lagging tech giant...
Plus, Wall Street's highest target on a major data platform...
Plus, a lidar leader riding the humanoid robot wave...
Plus, a Bitcoin miner is pivoting to AI data centers with 99% potential upside...
Plus, a human-first tech company a top analyst calls AI-proof...
Plus, an AI-powered drugmaker's hair loss breakthrough...
Plus, a top analyst says this oil and gas stock has 50% more value in unpumped reserves ...
Plus, for members only: the next chapter of The Street Sheet is here.
Plus, a biotech with a whopping 75% potential upside...
Plus, a hardware giant whose AI backlog forced a target jump from $29 to $74...
Plus, the third-best analyst on Wall Street’s 44% upside call.
Plus, a grid intelligence leader with a record $4.4B backlog.
Plus, a Top 1% analyst weighs in on Wall Street's biggest stock.
Plus, a Top 1% UBS stock picker sees almost 50% upside on this chipmaker, and more.
Plus, the 9th best analyst on Wall Street's favorite AI call, and more.
